Pain Management
Conditions
Keywords
Morphine, acetaminophen, Acute pain, Analgesics
Brief summary
In emergency medicine, acute pain is a common reason for consultation. It is recommended that patients in moderate to severe pain should receive a combination of intravenous acetaminophen and morphine. However, the data are sparse to support this strategy. Thus, the purpose of our research is to test non-inferiority of IV morphine alone versus IV acetaminophen and morphine in a multicenter, randomized, controlled double blind trial in ED patients with moderate to severe acute pain.
Detailed description
This study is designed to assess whether IV morphine alone is non inferior to combination IV acetaminophen and morphine for the management of moderate to severe pain in the ED. Numeric rating scale pain score will be compared between those who receive morphine alone and who will receive acetaminophen and morphine at 15, 30, 45 and 60 min post first injection.
Interventions
DRUGplacebo of acetaminophen IV
Mophine IV: Initial loading dose of 0.1 mg/kg (ensuring that the maximum dose of 10 mg is not exceeded) followed by bolus of 0.05 mg/kg every 10 minutes (taking care not to exceed the maximum dose of 5 mg) as reported by the recommandation of experts of the french society of urgency care. Placebo of acetaminophen IV: Sodium chloride 0.9%
DRUGacetaminophen IV
Mophine IV: Initial loading dose of 0.1 mg/kg (ensuring that the maximum dose of 10 mg is not exceeded) followed by bolus of 0.05 mg/kg every 10 minutes ((taking care not to exceed the maximum dose of 5 mg) as reported by the recommandation of experts of the french society of urgency care. Acetaminophen IV: 1 g
Sponsors
Nantes University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
double blind
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 Years and older * Moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5. * Conscious patient * Clinical stability at the physician's discretion * Patient able to talk and give a verbal assessment of his/her pain with the numerical verbal scale * Out of guardianship and/or tutorship * Affiliated to the social security plan.
Exclusion criteria
* Pregnancy and Breast-feeding * Patient Unable to give numeric rating scale scores * Patient with a weight strictly less than 50kg. * acute pulmonary edema, acute respiratory failure * Acute coronary syndrome or unbalanced ischemic heart disease in progress. * Acute alcoholic intoxication. * Patient who received morphine, or acetaminophen, or analgesic, or anti-inflammatory, for the current acute pain episode, within 8 hours prior to arrival at the emergencies * No possibility of having venous access * History of chronic pain during treatment. * Allergy, intolerance or know contraindication to paracetamol or morphine or to an excipient. * Renal or hepatic insufficiency. * Association with buprenorphine, nalbuphine and pentazocine. * Patient unable or unable to give written consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of numeric rating scale pain scores between those who received morphine alone and who received combination of acetaminophen and morphine at 30 minutes. | 30 minutes | The Numerical Pain Rating Scale measures the perception of pain intensity with an eleven-point numerical scale. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of numeric rating scale pain scores between those who received morphine alone and who received the combination of acetaminophen and morphine at 10min, 20 min, 45 min and 60min. | 60 minutes | The Numerical Pain Rating Scale measures the perception of pain intensity with an eleven-point numerical scale. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain). |
| Estimated cumulative dose of morphine in both arms at a dose -by-weight (mg/kg) dose during the first 30 minutes | 30 minutes | — |
| Frequency and intensity of adverse reactions: nausea, vomiting, respiratory failure, hypotension | through study completion, an average of 60 minutes | — |
Countries
France
Outcome results
None listed